|
WO2021034985A1
|
|
Compositions and methods for modulating splicing and protein expression
|
|
WO2020219977A1
|
|
Methods and compositions for modulating splicing of alternative introns
|
|
WO2020219934A1
|
|
Methods and compositions for modulating splicing and translation
|
|
WO2020176776A1
|
|
Antisense oligomers for treatment of conditions and diseases
|
|
EP3788169A1
|
|
Methods and compositions for treatment of cholesteryl ester storage disease
|
|
GB202006322D0
|
|
Antisense oligomers for treatment of non-sense mediated RNA decay based conditions and diseases
|
|
GB202020677D0
|
|
Antisense oligomers for treatment of conditions an diseases
|
|
US2019070213A1
|
|
Antisense oligomers and uses thereof
|
